CLL is defined by the presence of a monoclonal B-cell population greater than 5 × 109/L in the peripheral blood, with classic phenotypic characteristics of CLL, which include CD5+, CD19+, and CD43+ [3,4]. Here, SPN is linked to B-cell chronic lymphocytic leukemia.